Published in Mol Neurobiol on February 01, 1998
Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev (2010) 2.13
Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch Gen Psychiatry (2009) 1.17
Prenatal alcohol exposure and chronic mild stress differentially alter depressive- and anxiety-like behaviors in male and female offspring. Alcohol Clin Exp Res (2010) 1.04
Epigenetic and genetic factors predict women's salivary cortisol following a threat to the social self. PLoS One (2012) 0.90
Gender differences in the effect of early life trauma on hypothalamic-pituitary-adrenal axis functioning. Depress Anxiety (2011) 0.90
Gender differences in stress response: Role of developmental and biological determinants. Ind Psychiatry J (2011) 0.86
Experimental models of stress. Dialogues Clin Neurosci (2006) 0.85
Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol Metab Clin North Am (2013) 0.83
Arrhythmia and sudden death associated with elevated cardiac chloride channel activity. J Cell Mol Med (2011) 0.77
Androgen receptor-mediated regulation of adrenocortical activity in the sand rat, Psammomys obesus. J Comp Physiol B (2014) 0.76
Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience (2000) 2.54
Melatonin: a coordinating signal for mammalian reproduction? Science (1985) 1.41
The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology (1996) 1.28
The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience (1994) 1.28
Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp Neurol (1996) 1.09
Implications of estrogen-dependent brain organization for gender differences in hypothalamo-pituitary-adrenal regulation. FASEB J (1995) 1.00
Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology (Berl) (1994) 0.98
Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro). Brain Res (1986) 0.98
Gonadal steroids exert facilitating and "buffering" effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. J Neurosci (1996) 0.98
Ligand and subfield specificity of corticoid-induced neuronal loss in the rat hippocampal formation. Neuroscience (1999) 0.97
Chronic alcohol consumption and withdrawal do not induce cell death in the suprachiasmatic nucleus, but lead to irreversible depression of peptide immunoreactivity and mRNA levels. J Neurosci (1997) 0.97
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest (1997) 0.96
Maintenance of hippocampal cell numbers in young and aged rats submitted to chronic unpredictable stress. Comparison with the effects of corticosterone treatment. Stress (1998) 0.95
Oxytocin binding sites in rat limbic and hypothalamic structures: site-specific modulation by adrenal and gonadal steroids. Neuroscience (1993) 0.91
Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur J Pharmacol (1994) 0.89
A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems. J Neurosci (1987) 0.88
Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Endocrinology (1994) 0.87
Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse (1993) 0.87
Stress- and corticosteroid-induced modulation of the locomotor response to morphine in rats. Behav Brain Res (1999) 0.86
Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion. J Endocrinol (1987) 0.86
Lactation as a model for naturally reversible hypercorticalism plasticity in the mechanisms governing hypothalamo-pituitary- adrenocortical activity in rats. J Clin Invest (1995) 0.86
Immunocytochemical demonstration of opioid receptors in selected rat brain areas and neuroblastoma x glioma hybrid (NG108-15) cells using a monoclonal anti-idiotypic antibody. Neuroscience (1989) 0.85
Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology (1995) 0.85
Absence of tolerance to the aversive stimulus properties of ethanol following oral ethanol self-administration. Alcohol (1996) 0.83
Feedback inhibition of opioid peptide release in the hypothalamus of the rat. Neuroscience (1987) 0.83
Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release. Biol Cell (1997) 0.81
Hypothalamic LH-RH release after acute and chronic treatment with morphine studied in a combined in vivo/in vitro model. Brain Res (1988) 0.81
Ontogeny of gender-specific responsiveness to stress and glucocorticoids in the rat and its determination by the neonatal gonadal steroid environment. Stress (1999) 0.81
Corticotropin-releasing factor (CRF) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro. Brain Res (1986) 0.80
Abolition of seasonal embryonic diapause in a wallaby by pineal denervation. Nature (1981) 0.80
Generation of melatonin rhythms. Ciba Found Symp (1985) 0.80
Plasticity of hippocampal corticosteroid receptors during aging in the rat. FASEB J (1999) 0.80
Photoperiodic regulation of reproductive activity in the ram: evidence for the involvement of circadian rhythms in melatonin and prolactin secretion. Biol Reprod (1982) 0.79
Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary. Neuroendocrinology (1986) 0.79
Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology (1998) 0.79
Exposure to a novel stimulus reduces anxiety level in adult and aging rats. Physiol Behav (2001) 0.79
Inherent glucocorticoid response potential of isolated hypothalamic neuroendocrine neurons. FASEB J (1998) 0.78
Corticosteroid regulation of gene expression and binding characteristics of vasopressin receptors in the rat brain. Eur J Neurosci (1995) 0.77
In vivo and in vitro studies of GABAergic inhibition of prolactin biosynthesis. Neuroendocrinology (1986) 0.77
Photoperiod-driven changes in reproductive function in male rhesus monkeys. J Clin Endocrinol Metab (1992) 0.77
Role of melatonin and circadian rhythms in seasonal reproduction in rams. J Reprod Fertil Suppl (1981) 0.77
Pituitary-adrenal function and hypothalamic beta-endorphin release in vitro following food deprivation. Brain Res Bull (1993) 0.76
Pre- and postsynaptic actions of GABA on the release of hypothalamic gonadotropin-releasing hormone (GnRH). Brain Res Bull (1988) 0.76
Significance of testosterone in regulating hypothalamic content and in vitro release of beta-endorphin and dynorphin. J Neurochem (1987) 0.76
Melatonin and malignant disease. Ciba Found Symp (1985) 0.76
A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins. Endocrinology (1989) 0.76
Reproductive photorefractoriness in rams and accompanying changes in the patterns of melatonin and prolactin secretion. Biol Reprod (1984) 0.76
Paradoxical LH and prolactin responses to naloxone after chronic treatment with morphine. J Endocrinol (1986) 0.75
Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release. Neuroscience (1989) 0.75
A reappraisal of the goitre-prevention assay: determination of the thyroid secretion rate in the Japanese quail and the relative potencies of T3 and T4 in preventing goitrogenesis. Gen Comp Endocrinol (1980) 0.75
Multiple factors influencing the in vitro release of [Met5]-enkephalin from rat hypothalamic slices. J Neurochem (1989) 0.75
Effects of feeding pattern on the pituitary--thyroid axis in the Japanese quail. Gen Comp Endocrinol (1981) 0.75
Inhibition of reproduction in rams by long daylengths and the acute effect of superior cervical ganglionectomy. J Reprod Fertil (1982) 0.75
Potency and specificity of a growth hormone-releasing factor in a primate and in vitro. J Clin Endocrinol Metab (1984) 0.75
Opioid modulation of LHRH release in vitro depends upon levels of testosterone in vivo. Neuroendocrinology (1986) 0.75
Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release. NIDA Res Monogr (1986) 0.75
Hypothalamic opioid receptors mediate the inhibitory actions of corticotropin-releasing hormone on luteinizing hormone release: further evidence from a morphine-tolerant animal model. Brain Res (1988) 0.75
Pertussis toxin inactivates the presynaptic serotonin autoreceptor in the hippocampus. Eur J Pharmacol (1988) 0.75
Hypothalamic secretion of thyrotrophin releasing hormone is decreased in male Japanese quail exposed to long daily photoperiods. J Endocrinol (1982) 0.75
A 'window of time' during which testosterone determines the opiatergic control of LH release in the adult male rat. J Reprod Fertil (1987) 0.75
Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin. Neuroendocrinology (1991) 0.75
Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor. Neuroendocrinology (1988) 0.75